279 related articles for article (PubMed ID: 24859746)
1. Dysfunctional Wnt/β-catenin signaling contributes to blood-brain barrier breakdown in Alzheimer's disease.
Liu L; Wan W; Xia S; Kalionis B; Li Y
Neurochem Int; 2014 Sep; 75():19-25. PubMed ID: 24859746
[TBL] [Abstract][Full Text] [Related]
2. Wnt signaling in Alzheimer's disease: up or down, that is the question.
Boonen RA; van Tijn P; Zivkovic D
Ageing Res Rev; 2009 Apr; 8(2):71-82. PubMed ID: 19101658
[TBL] [Abstract][Full Text] [Related]
3. Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease.
Fuentealba RA; Farias G; Scheu J; Bronfman M; Marzolo MP; Inestrosa NC
Brain Res Brain Res Rev; 2004 Dec; 47(1-3):275-89. PubMed ID: 15572177
[TBL] [Abstract][Full Text] [Related]
4. Two sides of the same coin: Wnt signaling in neurodegeneration and neuro-oncology.
Caricasole A; Bakker A; Copani A; Nicoletti F; Gaviraghi G; Terstappen GC
Biosci Rep; 2005; 25(5-6):309-27. PubMed ID: 16307379
[TBL] [Abstract][Full Text] [Related]
5. Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils.
De Ferrari GV; Chacón MA; Barría MI; Garrido JL; Godoy JA; Olivares G; Reyes AE; Alvarez A; Bronfman M; Inestrosa NC
Mol Psychiatry; 2003 Feb; 8(2):195-208. PubMed ID: 12610652
[TBL] [Abstract][Full Text] [Related]
6. Wnt/β-catenin signaling in Alzheimer's disease.
De Ferrari GV; Avila ME; Medina MA; Perez-Palma E; Bustos BI; Alarcon MA
CNS Neurol Disord Drug Targets; 2014; 13(5):745-54. PubMed ID: 24365184
[TBL] [Abstract][Full Text] [Related]
7. Synaptotoxicity in Alzheimer's disease: the Wnt signaling pathway as a molecular target.
Inestrosa NC; Varela-Nallar L; Grabowski CP; Colombres M
IUBMB Life; 2007; 59(4-5):316-21. PubMed ID: 17505971
[TBL] [Abstract][Full Text] [Related]
8. Polyethylenimine-cationized beta-catenin protein transduction activates the Wnt canonical signaling pathway more effectively than cationic lipid-based transduction.
Kitazoe M; Futami J; Nishikawa M; Yamada H; Maeda Y
Biotechnol J; 2010 Apr; 5(4):385-92. PubMed ID: 20235145
[TBL] [Abstract][Full Text] [Related]
9. Activation of Wnt/β-catenin pathway mitigates blood-brain barrier dysfunction in Alzheimer's disease.
Wang Q; Huang X; Su Y; Yin G; Wang S; Yu B; Li H; Qi J; Chen H; Zeng W; Zhang K; Verkhratsky A; Niu J; Yi C
Brain; 2022 Dec; 145(12):4474-4488. PubMed ID: 35788280
[TBL] [Abstract][Full Text] [Related]
10. Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer's disease.
Jia L; Piña-Crespo J; Li Y
Mol Brain; 2019 Dec; 12(1):104. PubMed ID: 31801553
[TBL] [Abstract][Full Text] [Related]
11. Evidence of Wnt/β-catenin alterations in brain and bone of a tauopathy mouse model of Alzheimer's disease.
Dengler-Crish CM; Ball HC; Lin L; Novak KM; Cooper LN
Neurobiol Aging; 2018 Jul; 67():148-158. PubMed ID: 29660685
[TBL] [Abstract][Full Text] [Related]
12. Calcium/calmodulin-dependent protein kinase type IV is a target gene of the Wnt/beta-catenin signaling pathway.
Arrázola MS; Varela-Nallar L; Colombres M; Toledo EM; Cruzat F; Pavez L; Assar R; Aravena A; González M; Montecino M; Maass A; Martínez S; Inestrosa NC
J Cell Physiol; 2009 Dec; 221(3):658-67. PubMed ID: 19711354
[TBL] [Abstract][Full Text] [Related]
13. Targeting the Wnt/β-catenin signaling pathway in human cancers.
Yao H; Ashihara E; Maekawa T
Expert Opin Ther Targets; 2011 Jul; 15(7):873-87. PubMed ID: 21486121
[TBL] [Abstract][Full Text] [Related]
14. Riluzole: a therapeutic strategy in Alzheimer's disease by targeting the WNT/β-catenin pathway.
Vallée A; Vallée JN; Guillevin R; Lecarpentier Y
Aging (Albany NY); 2020 Feb; 12(3):3095-3113. PubMed ID: 32035419
[TBL] [Abstract][Full Text] [Related]
15. β-Catenin Is Required for Endothelial Cyp1b1 Regulation Influencing Metabolic Barrier Function.
Ziegler N; Awwad K; Fisslthaler B; Reis M; Devraj K; Corada M; Minardi SP; Dejana E; Plate KH; Fleming I; Liebner S
J Neurosci; 2016 Aug; 36(34):8921-35. PubMed ID: 27559173
[TBL] [Abstract][Full Text] [Related]
16. Wnt/β-catenin signal pathway stabilizes APP intracellular domain (AICD) and promotes its transcriptional activity.
Zhou F; Gong K; van Laar T; Gong Y; Zhang L
Biochem Biophys Res Commun; 2011 Aug; 412(1):68-73. PubMed ID: 21798242
[TBL] [Abstract][Full Text] [Related]
17. Endothelial Wnt/β-catenin signaling reduces immune cell infiltration in multiple sclerosis.
Lengfeld JE; Lutz SE; Smith JR; Diaconu C; Scott C; Kofman SB; Choi C; Walsh CM; Raine CS; Agalliu I; Agalliu D
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):E1168-E1177. PubMed ID: 28137846
[TBL] [Abstract][Full Text] [Related]
18. Frizzled-1 is involved in the neuroprotective effect of Wnt3a against Abeta oligomers.
Chacón MA; Varela-Nallar L; Inestrosa NC
J Cell Physiol; 2008 Oct; 217(1):215-27. PubMed ID: 18521822
[TBL] [Abstract][Full Text] [Related]
19. [Blood-brain barrier and Alzheimer's disease].
Kuwahara H; Nishida Y; Yokota T
Brain Nerve; 2013 Feb; 65(2):145-51. PubMed ID: 23399672
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease.
Donahue JE; Johanson CE
J Neuropathol Exp Neurol; 2008 Apr; 67(4):261-70. PubMed ID: 18379441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
